Is Aurobindo Pharma Debt Free?
What Is Aurobindo Pharma’s Debt? The image below, which you can click on for greater detail, shows that Aurobindo Pharma had debt of ₹43.9b at the end of September 2021, a reduction from ₹49.9b over a year. However, its balance sheet shows it holds ₹45.0b in cash, so it actually has ₹1.08b net cash.
Is Aurobindo Pharma a good buy now?
Brokerage firm HDFC Securities has recommended to ‘buy’ Aurobindo Pharma’s stock with a potential upside of ~46%.
Is Aurobindo Pharma a good company?
A Good Company with Overall Good work culture and salary profile. Located in Hyderabad, Management with excellent capability in terms of finance and Technology. Latest technology adoption, good facility and good salary structure.
Who is the owner of Aurobindo Pharma?
. P. V. Ramaprasad Reddy
Aurobindo Pharma was founded in 1986 by Mr. P. V. Ramaprasad Reddy and Mr.
What is Aurobindo Pharma used for?
The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic/product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics.
Why do lupins fall?
What brokerages say. Shares of Lupin continued to decline for the second consecutive day on Thursday after the company’s earnings missed street’s expectations due to a dip in US sales in the June quarter and lower gross margin.
Is Aurobindo safe?
India’s Aurobindo Pharma has been one of the culprits found manufacturing the high blood pressure medicine valsartan with high levels of impurities that carry a risk of cancer. Now the FDA has savaged it in a warning letter for missteps that paved the pathway to the mess.
Should I invest in Lupin?
Long-term investors should start accumulating Lupin at current prices for the near-term targets of Rs 1083-1160. While Rs 960-883 will be excellent support levels,” AR Ramachandran, Co-founder & Trainer, Tips2Trades, told Financial Express Online.
What is the future of Lupin share?
Lupin Limited quote is equal to 899.000 INR at 2021-12-26. Based on our forecasts, a long-term increase is expected, the “LUPIN” stock price prognosis for 2026-12-21 is 1594.710 INR. With a 5-year investment, the revenue is expected to be around +77.39%. Your current $100 investment may be up to $177.39 in 2026.